# Endoscopic and Surgical Treatment in Early Gastric Cancer: The Gray Zone in Treatment Decision-Making from the Perspectives of Endoscopists

## TL;DR

This paper discusses the challenges in deciding between endoscopic and surgical treatments for early gastric cancer, highlighting a 'gray zone' of uncertainty.

## Contribution

The paper emphasizes the need to refine endoscopic treatment indications based on endoscopic outcomes rather than surgical ones.

## Key findings

- The 'gray zone' arises from ambiguities in predicting treatment outcomes before endoscopic or surgical resection.
- Differences in tissue handling between surgery and endoscopy contribute to treatment decision uncertainties.
- Endoscopic treatment indications should be developed independently from surgical outcome analyses.

## Abstract

When determining the treatment for early gastric cancer, several factors must be considered to decide between endoscopic treatment and surgery. There are limitations in the information available before treatment, making it difficult to predict the final outcome. This leads to the occurrence of the “gray zone”. This article examines these factors and highlights issues related to diagnosis, endoscopic treatment, and tissue-handling processes from the perspective of endoscopists. In particular, this article points out issues arising from differences in the anatomical location and handling processes of the obtained tissue between surgery and endoscopic procedures. Since the handling processes of tissue in surgery and endoscopy are inherently different, this article emphasizes that the endoscopic treatment indications derived from surgical outcome analyses should be further developed based on the results from endoscopic treatment.

To treat early gastric cancer, one must choose between endoscopic treatment and surgical treatment. Endoscopic treatment has been developing significantly since the late 1990s and has made great progress up to the present. However, many patients with early gastric cancer still undergo unnecessary surgery or endoscopic procedures. This is due to the existence of a “gray zone” of ambiguities between endoscopic and surgical treatment. These ambiguities arise because the important factors in determining the treatment for early gastric cancer can only be fully understood after endoscopic or surgical resection or because of discrepancies between the factors identifiable before treatment and those identifiable after treatment. This article aims to explore these ambiguous factors and discuss methods and efforts to reduce them.